Annual Shareholders Equity
$21.00 M
-$2.79 M-11.74%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual stockholders equity is $21.00 million, with the most recent change of -$2.79 million (-11.74%) on December 1, 2023.
- During the last 3 years, CSCI annual shareholders equity has risen by +$1.93 million (+10.14%).
- CSCI annual shareholders equity is now -11.74% below its all-time high of $23.79 million, reached on December 1, 2022.
Performance
CSCI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$20.01 M
-$6.21 M-23.69%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly stockholders equity is $20.01 million, with the most recent change of -$6.21 million (-23.69%) on September 1, 2024.
- Over the past year, CSCI quarterly shareholders equity has dropped by -$983.40 thousand (-4.68%).
- CSCI quarterly shareholders equity is now -23.69% below its all-time high of $26.23 million, reached on June 1, 2024.
Performance
CSCI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CSCI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.7% | -4.7% |
| 3 y3 years | +10.1% | -4.7% |
| 5 y5 years | +23.2% | -4.7% |
CSCI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.7% | at low | -23.7% | +4.1% |
| 5 y | 5-year | -11.7% | +22.9% | -23.7% | +20.6% |
| alltime | all time | -11.7% | +1416.9% | -23.7% | +1356.3% |
COSCIENS Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.01 M(-23.7%) |
| Jun 2024 | - | $26.23 M(+36.4%) |
| Mar 2024 | - | $19.23 M(-8.4%) |
| Dec 2023 | $21.00 M(-11.7%) | $21.00 M(-4.7%) |
| Sep 2023 | - | $22.04 M(-5.6%) |
| Jun 2023 | - | $23.35 M(-1.4%) |
| Mar 2023 | - | $23.69 M(-0.4%) |
| Dec 2022 | $23.79 M(+9.4%) | $23.79 M(+2.1%) |
| Sep 2022 | - | $23.30 M(-3.0%) |
| Jun 2022 | - | $24.02 M(+2.7%) |
| Mar 2022 | - | $23.40 M(+7.6%) |
| Dec 2021 | $21.74 M(+14.0%) | $21.74 M(+5.0%) |
| Sep 2021 | - | $20.71 M(+0.6%) |
| Jun 2021 | - | $20.59 M(+4.6%) |
| Mar 2021 | - | $19.69 M(+3.3%) |
| Dec 2020 | $19.06 M(+11.6%) | $19.06 M(+2.8%) |
| Sep 2020 | - | $18.55 M(+2.9%) |
| Jun 2020 | - | $18.03 M(+8.7%) |
| Mar 2020 | - | $16.59 M(-2.9%) |
| Dec 2019 | $17.08 M(+0.2%) | $17.08 M(+2.2%) |
| Sep 2019 | - | $16.71 M(-1.1%) |
| Jun 2019 | - | $16.90 M(-0.5%) |
| Mar 2019 | - | $16.98 M(-0.4%) |
| Dec 2018 | $17.04 M(-4.9%) | $17.04 M(-3.0%) |
| Sep 2018 | - | $17.58 M(+4.4%) |
| Jun 2018 | - | $16.83 M(-3.1%) |
| Mar 2018 | - | $17.37 M(-3.1%) |
| Dec 2017 | $17.93 M(+7.6%) | $17.93 M(-7.3%) |
| Sep 2017 | - | $19.35 M(+6.3%) |
| Jun 2017 | - | $18.20 M(+4.9%) |
| Mar 2017 | - | $17.35 M(+4.4%) |
| Dec 2016 | $16.67 M(+193.6%) | $16.61 M(+3.9%) |
| Sep 2016 | - | $15.99 M(+89.7%) |
| Jun 2016 | - | $8.43 M(+19.5%) |
| Mar 2016 | - | $7.05 M(+24.3%) |
| Dec 2015 | $5.68 M(+215.0%) | $5.68 M(+80.8%) |
| Sep 2015 | - | $3.14 M(+26.2%) |
| Jun 2015 | - | $2.49 M(+36.3%) |
| Mar 2015 | - | $1.83 M(+1.3%) |
| Dec 2014 | $1.80 M(+684.9%) | $1.80 M(+3.5%) |
| Sep 2014 | - | $1.74 M(+49.9%) |
| Jun 2014 | - | $1.16 M(+167.2%) |
| Mar 2014 | - | $434.70 K(+89.3%) |
| Dec 2013 | $229.60 K(+1588.2%) | $229.60 K(-30.0%) |
| Sep 2013 | - | $328.00 K(+66.9%) |
| Jun 2013 | - | $196.50 K(-55.0%) |
| Mar 2013 | - | $436.20 K(+3107.4%) |
| Dec 2012 | $13.60 K(-97.3%) | $13.60 K(-94.6%) |
| Sep 2012 | - | $251.00 K(-29.5%) |
| Jun 2012 | - | $356.10 K(-31.9%) |
| Mar 2012 | - | $523.10 K(+3.1%) |
| Dec 2011 | $507.10 K(-177.4%) | $507.20 K(-316.7%) |
| Sep 2011 | - | -$234.10 K(+56.5%) |
| Jun 2011 | - | -$149.60 K(-46.9%) |
| Mar 2011 | - | -$281.70 K(-57.0%) |
| Dec 2010 | -$654.90 K | -$654.90 K(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | -$699.70 K(-34.7%) |
| Jun 2010 | - | -$1.07 M(-22.1%) |
| Mar 2010 | - | -$1.38 M(+5.7%) |
| Dec 2009 | -$1.31 M(-17.4%) | -$1.30 M(+69.7%) |
| Sep 2009 | - | -$767.50 K(+6.3%) |
| Jun 2009 | - | -$721.80 K(-49.8%) |
| Mar 2009 | - | -$1.44 M(-8.3%) |
| Dec 2008 | -$1.59 M(-201.1%) | -$1.57 M(+210.4%) |
| Sep 2008 | - | -$504.90 K(+484.4%) |
| Jun 2008 | - | -$86.40 K(-109.0%) |
| Mar 2008 | - | $962.20 K(-38.2%) |
| Dec 2007 | $1.57 M(+502.0%) | $1.56 M(-24.4%) |
| Sep 2007 | - | $2.06 M(-12.8%) |
| Jun 2007 | - | $2.36 M(+829.3%) |
| Mar 2007 | - | $254.10 K(-2.5%) |
| Dec 2006 | $260.60 K(-34.4%) | $260.50 K(-10.5%) |
| Sep 2006 | - | $291.10 K(-22.9%) |
| Jun 2006 | - | $377.40 K(+4.9%) |
| Mar 2006 | - | $359.70 K(-9.4%) |
| Dec 2005 | $397.20 K(+318.5%) | $397.00 K(+67.0%) |
| Sep 2005 | - | $237.70 K(+6.8%) |
| Jun 2005 | - | $222.50 K(+55.6%) |
| Mar 2005 | - | $143.00 K(+50.7%) |
| Dec 2004 | $94.90 K(-67.8%) | $94.90 K(-3.3%) |
| Sep 2004 | - | $98.10 K(-72.1%) |
| Jun 2004 | - | $351.30 K(-11.6%) |
| Mar 2004 | - | $397.20 K(+35.0%) |
| Dec 2003 | $294.80 K(-171.1%) | $294.30 K(+46.7%) |
| Sep 2003 | - | $200.60 K(-205.1%) |
| Jun 2003 | - | -$190.80 K(-53.4%) |
| Mar 2003 | - | -$409.60 K(-1.0%) |
| Dec 2002 | -$414.80 K(-41.9%) | -$413.80 K(-16.5%) |
| Sep 2002 | - | -$495.30 K(-25.4%) |
| Jun 2002 | - | -$664.10 K(-2.1%) |
| Mar 2002 | - | -$678.40 K(-4.7%) |
| Dec 2001 | -$714.40 K(-55.2%) | -$712.00 K(-2.0%) |
| Sep 2001 | - | -$726.20 K(-25.1%) |
| Jun 2001 | - | -$970.10 K(-32.1%) |
| Mar 2001 | - | -$1.43 M(-10.4%) |
| Dec 2000 | -$1.59 M(+21.5%) | -$1.59 M(+5.7%) |
| Sep 2000 | - | -$1.51 M(+1.5%) |
| Jun 2000 | - | -$1.49 M(+2.7%) |
| Mar 2000 | - | -$1.45 M(+10.6%) |
| Dec 1999 | -$1.31 M(+83.5%) | -$1.31 M(+37.0%) |
| Sep 1999 | - | -$953.90 K(+17.5%) |
| Jun 1999 | - | -$812.10 K(+2.1%) |
| Mar 1999 | - | -$795.20 K(+11.9%) |
| Dec 1998 | -$714.90 K(-110.9%) | -$710.60 K(-122.6%) |
| Sep 1998 | - | $3.15 M(-48.7%) |
| Jun 1998 | - | $6.14 M(-4.0%) |
| Mar 1998 | - | $6.39 M(-2.5%) |
| Dec 1997 | $6.57 M(+12.5%) | $6.56 M(-59.6%) |
| Sep 1997 | - | $16.22 M(-8.4%) |
| Jun 1997 | - | $17.70 M(-31.0%) |
| Mar 1997 | - | $25.65 M |
| Dec 1996 | $5.84 M | - |
FAQ
- What is COSCIENS Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual shareholders equity year-on-year change?
- What is COSCIENS Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly shareholders equity year-on-year change?
What is COSCIENS Biopharma annual stockholders equity?
The current annual shareholders equity of CSCI is $21.00 M
What is the all time high annual shareholders equity for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual stockholders equity is $23.79 M
What is COSCIENS Biopharma annual shareholders equity year-on-year change?
Over the past year, CSCI annual stockholders equity has changed by -$2.79 M (-11.74%)
What is COSCIENS Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of CSCI is $20.01 M
What is the all time high quarterly shareholders equity for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly stockholders equity is $26.23 M
What is COSCIENS Biopharma quarterly shareholders equity year-on-year change?
Over the past year, CSCI quarterly stockholders equity has changed by -$983.40 K (-4.68%)